SHL Telemedicine Ltd
LSE:0QMX

Watchlist Manager
SHL Telemedicine Ltd Logo
SHL Telemedicine Ltd
LSE:0QMX
Watchlist
Price: 19 CHF 24.35% Market Closed
Market Cap: CHf274.9m

Wall St Price Targets

0QMX Price Targets Summary
SHL Telemedicine Ltd

There are no price targets for 0QMX.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
SHL Telemedicine Ltd Competitors:
Price Targets
PHVS
Pharvaris NV
36% Upside
CNC
Concurrent Technologies PLC
21% Upside
TNDM
Tandem Diabetes Care Inc
91% Upside

Revenue
Forecast

1% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat
1% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat

Over the last 14 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 8 years is 1%.

Gross Profit
Forecast

-2% / Year
Past Growth
-1% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-2% / Year
Past Growth
-1% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 14 years, the compound annual growth rate for Gross Profit has been -2%. The projected CAGR for the next 10 years is -1%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
12%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
12%
Average Beat

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
10%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
10%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 0QMX's stock price target?
Not Available

0QMX does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for SHL Telemedicine Ltd?
Projected CAGR
1%

Over the last 14 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 8 years is 1%.

What is the Gross Profit forecast for SHL Telemedicine Ltd?
Projected CAGR
-1%

Over the last 14 years, the compound annual growth rate for Gross Profit has been -2%. The projected CAGR for the next 10 years is -1%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett